cdmo.directory
← Compare landing

ADViRNA vs Biospring

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryADViRNABiospring
SummaryADViRNA provides oligonucleotide design, synthesis, and screening services with proprietary chemical modifications and conjugation technologies for therapeutic siRNA and ASO development.Global CDMO leader in nucleic acid manufacturing and analysis (mRNA, ASO, siRNA, guide RNA, oligonucleotides) with nearly three decades of expertise, GMP certification since 2007, and support for 9 commercial programs across all clinical phases.
Services
  • Translational Research
  • Bioconjugation Services
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Oligonucleotide
  • Oligonucleotide
  • mRNA
Development capabilities
  • Analytical method development
  • Analytical method development
  • ICH stability testing
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Substance (DS)
  • Drug Product (DP)
  • Max chemical: Commercial (>100 kg / tonne)
LocationsData not yet provided.
  • Headquarters
CertificationsData not yet provided.
  • GMP · Identifier: GMP certified since 2007
  • FDA · Identifier: FDA inspected
  • ANVISA · Identifier: ANVISA inspected

Find similar companies

ADViRNA alternatives · Biospring alternatives

Markdown mirror: /compare/advirna/biospring.md